Yanni Souroutzidis

Stock Analyst at Cantor Fitzgerald

(n/a)
# 5,142
Out of 5,182 analysts
1
Total ratings
n/a
Success rate
-24.31%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Yanni Souroutzidis

Karyopharm Therapeutics
Feb 5, 2026
Initiates: Overweight
Price Target: n/a
Current: $7.21
Upside: -